Goldman Sachs Group INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: Goldman Sachs Discloses 2.4% Passive Stake in Array Technologies
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a 2.4% beneficial ownership stake in Array Technologies, Inc. as of December 31, 2024.
NYSE
SCHEDULE 13G: Goldman Sachs Discloses 6.3% Stake in Agriculture & Natural Solutions Acquisition Corporation
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 6.3% in Agriculture & Natural Solutions Acquisition Corporation's Class A ordinary shares as of December 31, 2024.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 5.5% in Vine Hill Capital Investment Corp.'s Class A ordinary shares.
NYSE
SCHEDULE 13G: Goldman Sachs Discloses 5.3% Stake in Silverbox Corp IV
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 5.3% in Silverbox Corp IV's Class A ordinary shares as of December 31, 2024.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a passive beneficial ownership of 6.6% in Silexion Therapeutics Corp., holding 112,242 ordinary shares as of December 31, 2024.
NYSE
Goldman Sachs Group and its affiliate, Goldman Sachs & Co. LLC, have reported a passive beneficial ownership of 3.0% in Rhythm Pharmaceuticals, Inc. as of December 31, 2024.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have jointly disclosed a beneficial ownership of 6.0% in DT Cloud Star Acquisition Corp, holding 536,967 ordinary shares as of December 31, 2024.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a 9.6% beneficial ownership stake in 4D Molecular Therapeutics, Inc. as of December 31, 2024, through an amended Schedule 13G filing.
NYSE
Multiple Goldman Sachs affiliated entities have filed an amendment to Schedule 13G, indicating they no longer hold a reportable beneficial ownership stake in Sterling Check Corp., with their aggregate ownership reduced to 0.0%.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 6.9% in Voyager Acquisition Corp.'s Class A ordinary shares as of December 31, 2024.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a 5.3% beneficial ownership stake in Triumph Group, Inc. as of December 31, 2024, held for passive investment purposes.
NYSE
SCHEDULE 13G/A: Goldman Sachs Discloses 6.3% Stake in Lesaka Technologies, Inc. via Amended SEC Filing
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, disclosing a beneficial ownership of 6.3% of Lesaka Technologies, Inc.'s common stock as of December 31, 2024.
NYSE
The Goldman Sachs Group, Inc. and its affiliate Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 6.5% in Indivior PLC's ordinary shares as of December 31, 2024.
NYSE
SCHEDULE 13G: Goldman Sachs Discloses 5.1% Stake in GAN Limited
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have disclosed a beneficial ownership of 5.1% in GAN Limited, totaling 2,312,597 ordinary shares.
NYSE
SCHEDULE 13G/A: Goldman Sachs Discloses 2.8% Passive Stake in Elevation Oncology
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting a passive beneficial ownership of 2.8% in Elevation Oncology, Inc. as of December 31, 2024.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed an amended Schedule 13G, reporting a 4.2% beneficial ownership stake in Brinker International, Inc. as of December 31, 2024.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a beneficial ownership of 6.0% in Black Spade Acquisition II Co.'s Class A ordinary shares.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 5.2% in GENEDX HOLDINGS CORP.'s Class A common stock.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 5.1% of Stronghold Digital Mining Inc.'s Class A common stock.